Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 13,632 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syringes. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
How did GRRMY's recent EPS compare to expectations?
The most recent EPS for Gerresheimer AG is $, expectations of $0.32.
How did Gerresheimer AG GRRMY's revenue perform in the last quarter?
Gerresheimer AG revenue for the last quarter is $
What is the revenue estimate for Gerresheimer AG?
According to 2 of Wall street analyst, the revenue estimate of Gerresheimer AG range from $631.04M to $588.98M
What's the earning quality score for Gerresheimer AG?
Gerresheimer AG has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Gerresheimer AG report earnings?
Gerresheimer AG next earnings report is expected in 2026-07-15
What are Gerresheimer AG's expected earnings?
Gerresheimer AG expected earnings is $520.15M, according to wall-street analysts.
Did Gerresheimer AG beat earnings expectations?
Gerresheimer AG recent earnings of $ expectations.